Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

Kawashima, Yosuke; Fukuhara, Tatsuro; Saito, Haruhiro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Seike, Masahiro; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nagashima, Hiromi; Asai, Gyo; Watanabe, Satoshi; Miyazaki, Masaki; Hagiwara, Koichi; Nukiwa, Toshihiro; Morita, Satoshi; Kobayashi, Kunihiko; Maemondo, Makoto

doi:https://doi.org/10.1016/s2213-2600(21)00166-1

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

インデックスツリー

アイテム

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

https://iwatemed.repo.nii.ac.jp/records/2000835

Item type

学術雑誌論文 / Journal Article(1)

公開日

2024-11-08

タイトル

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

言語

eng

資源タイプ

資源タイプ識別子

http://purl.org/coar/resource_type/c_6501

資源タイプ

journal article

アクセス権

metadata only access

アクセス権URI

http://purl.org/coar/access_right/c_14cb

著者

Kawashima, Yosuke
Fukuhara, Tatsuro
Saito, Haruhiro
Furuya, Naoki
Watanabe, Kana
Sugawara, Shunichi
Iwasawa, Shunichiro
Tsunezuka, Yoshio
Yamaguchi, Ou
Okada, Morihito
Yoshimori, Kozo
Nakachi, Ichiro
Seike, Masahiro
Azuma, Koichi
Kurimoto, Futoshi
Tsubata, Yukari
Fujita, Yuka
Nagashima, Hiromi
Asai, Gyo
Watanabe, Satoshi
Miyazaki, Masaki
Hagiwara, Koichi
Nukiwa, Toshihiro
Morita, Satoshi
Kobayashi, Kunihiko
Maemondo, Makoto

bibliographic_information

en : The Lancet. Respiratory medicine

巻 10, 号 1, p. 72-82, 発行日 2022-01

出版者

Oxford Elsevier

言語

item_10001_source_id_9

収録物識別子タイプ

PISSN

収録物識別子

2213-2600

Versions

Ver.1

2024-11-12 02:03:37.566104

Show All versions

Cite as

エクスポート

OAI-PMH

JPCOAR 2.0
JPCOAR 1.0
DublinCore
DDI

Other Formats

JSON
BIBTEX

インデックスリンク

インデックスツリー

アイテム

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

× Kawashima, Yosuke

× Fukuhara, Tatsuro

× Saito, Haruhiro

× Furuya, Naoki

× Watanabe, Kana

× Sugawara, Shunichi

× Iwasawa, Shunichiro

× Tsunezuka, Yoshio

× Yamaguchi, Ou

× Okada, Morihito

× Yoshimori, Kozo

× Nakachi, Ichiro

× Seike, Masahiro

× Azuma, Koichi

× Kurimoto, Futoshi

× Tsubata, Yukari

× Fujita, Yuka

× Nagashima, Hiromi

× Asai, Gyo

× Watanabe, Satoshi

× Miyazaki, Masaki

× Hagiwara, Koichi

× Nukiwa, Toshihiro

× Morita, Satoshi

× Kobayashi, Kunihiko

× Maemondo, Makoto

Versions

Share

Cite as

エクスポート